These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2139527)
21. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors]. Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST Vopr Onkol; 1984; 30(10):19-25. PubMed ID: 6093380 [TBL] [Abstract][Full Text] [Related]
22. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826 [TBL] [Abstract][Full Text] [Related]
23. [Morphological characteristics of osteogenic sarcoma after chemo-and radiotherapy]. Fedorova EN Arkh Patol; 1981; 43(5):51-6. PubMed ID: 6945073 [TBL] [Abstract][Full Text] [Related]
24. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor]. Kosmiadi GA; Grigor'eva MP; Govallo VI Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012 [TBL] [Abstract][Full Text] [Related]
25. En block surgery for osteogenic sarcoma: analysis and review of ninety operative cases. Marcove RC; Abou-Zahr K Bull N Y Acad Med; 1984 Sep; 60(7):748-58. PubMed ID: 6593105 [No Abstract] [Full Text] [Related]
26. [The characteristics of eicosanoid synthesis in osteogenic sarcoma in children at puberty]. Kushlinskiĭ NE; Bassalyk LS; Liakina LT; Solov'ev IuN; Pashkov IuV; Amiraslanov AT; Siniukov PA; Valenteĭ LV; Fedenko AN; Abaev VM Vopr Onkol; 1992; 38(8):929-35. PubMed ID: 1300802 [TBL] [Abstract][Full Text] [Related]
27. [Studies on various parameters of the T-dependent lymphocyte system in the course of osteosarcoma]. Marinoni I; Torelli L Boll Ist Sieroter Milan; 1976; 55(6):548-52. PubMed ID: 1088075 [TBL] [Abstract][Full Text] [Related]
28. Lymph node metastasis in osteogenic sarcoma. Cáceres E; Zaharia M; Tantalean E Surgery; 1969 Mar; 65(3):421-2. PubMed ID: 5250066 [No Abstract] [Full Text] [Related]
29. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors]. Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589 [TBL] [Abstract][Full Text] [Related]
30. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971 [TBL] [Abstract][Full Text] [Related]
31. [Pre- and postoperative anatomo-clinical correlations apropos of 30 conservative resections of osteogenic sarcomas. Surgical inferences]. Missenard G; Dubousset J; Genin J; Contesso G Rev Chir Orthop Reparatrice Appar Mot; 1986; 72(7):477-83. PubMed ID: 3469696 [TBL] [Abstract][Full Text] [Related]
32. Preliminary observation on the correlation between nm23 expression and Ki-67 antigen with early metastasis of human osteosarcoma. Liao W; Chiu KY; Han S; Li F; Qiu J; Chow SP Chin Med J (Engl); 1998 Sep; 111(9):813-7. PubMed ID: 11155673 [TBL] [Abstract][Full Text] [Related]
33. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy. Sears HF; Simon R; Rosenberg SA Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004 [TBL] [Abstract][Full Text] [Related]
34. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study. Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of osteosarcomas. Comparison with computed tomography. Zimmer WD; Berquist TH; McLeod RA; Sim FH; Pritchard DJ; Shives TC; Wold LE; May GR Clin Orthop Relat Res; 1986 Jul; (208):289-99. PubMed ID: 3459602 [TBL] [Abstract][Full Text] [Related]
36. [Decreased count of small lymphocytes in the blood of patients with malignant bone tumors]. Govallo VI; Grigor'eva MP; Kosmiadi GA; Efimtseva NN; Baranovskaia VT Vopr Onkol; 1987; 33(9):15-21. PubMed ID: 3499033 [TBL] [Abstract][Full Text] [Related]
37. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis. Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797 [TBL] [Abstract][Full Text] [Related]
38. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma. Rodriguez-Galindo C; Poquette CA; Daw NC; Tan M; Meyer WH; Cleveland JL Med Pediatr Oncol; 2001 Jun; 36(6):605-11. PubMed ID: 11344491 [TBL] [Abstract][Full Text] [Related]
39. time dependency of prognostic factors in patients with stage II osteosarcomas. Kim MS; Cho WH; Song WS; Lee SY; Jeon DG Clin Orthop Relat Res; 2007 Oct; 463():157-65. PubMed ID: 17621233 [TBL] [Abstract][Full Text] [Related]
40. [Unusual evolution of a diaphyseal osteogenic sarcoma]. De Santis E; Rosa MA Arch Putti Chir Organi Mov; 1981; 31():317-20. PubMed ID: 6954883 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]